Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-21 4:30 pm Unchanged | 13D | NEVRO CORP NVRO | Engaged Capital LLC | 2,168,163 6% | 0 (Unchanged) | View |
2024-02-14 4:13 pm Purchase | 13G | NEVRO CORP NVRO | ALGER ASSOCIATES INC | 2,115,664 5.8% | 874,249 (+70.42%) | View |
2024-02-14 3:47 pm Purchase | 13G | NEVRO CORP NVRO | ARMISTICE CAPITAL LLC | 3,176,000 8.76% | 3,176,000 (New Position) | View |
2024-02-14 3:38 pm Purchase | 13G | NEVRO CORP NVRO | ArrowMark Colorado Holdings LLC | 3,011,059 8.3% | 2,437,033 (+424.55%) | View |
2024-02-13 5:09 pm Sale | 13G | NEVRO CORP NVRO | VANGUARD GROUP INC | 4,067,271 11.23% | -38,079 (-0.93%) | View |
2024-01-24 5:23 pm Sale | 13G | NEVRO CORP NVRO | BlackRock Inc. BLK | 3,374,031 9.3% | -1,222,355 (-26.59%) | View |
2023-12-11 09:00 am Purchase | 13D | NEVRO CORP NVRO | Engaged Capital LLC | 2,168,163 6% | 2,168,163 (New Position) | View |
2023-09-11 08:23 am Sale | 13G | NEVRO CORP NVRO | FMR LLC | 1,080,739 2.992% | -2,164,928 (-66.70%) | View |
2023-06-12 08:21 am Sale | 13G | NEVRO CORP NVRO | FMR LLC | 3,245,667 9.057% | -1,959,281 (-37.64%) | View |
2023-02-14 12:38 pm Sale | 13G | NEVRO CORP NVRO | PRICE T ROWE ASSOCIATES INC | 280,434 0.7% | -2,048,097 (-87.96%) | View |
2023-02-09 7:18 pm Unchanged | 13G | NEVRO CORP NVRO | Jackson Square Partners LLC | 0 0% | 0 (Unchanged) | View |
2023-02-09 12:01 pm Purchase | 13G | NEVRO CORP NVRO | FMR LLC | 5,204,948 14.683% | 1,458,450 (+38.93%) | View |
2023-02-09 11:27 am Purchase | 13G | NEVRO CORP NVRO | VANGUARD GROUP INC | 4,105,350 11.59% | 544,554 (+15.29%) | View |
2023-01-23 3:52 pm Purchase | 13G | NEVRO CORP NVRO | BlackRock Inc. BLK | 4,596,386 13% | 446,155 (+10.75%) | View |
2023-01-20 06:54 am Purchase | 13G | NEVRO CORP NVRO | NORGES BANK | 1,805,980 5.1% | 1,805,980 (New Position) | View |
2022-11-07 1:36 pm Sale | 13G | NEVRO CORP NVRO | Jackson Square Partners LLC | 0 0% | -2,443,095 (Position Closed) | View |
2022-09-12 11:13 am Purchase | 13G | NEVRO CORP NVRO | FMR LLC | 3,746,498 10.581% | 2,519,423 (+205.32%) | View |
2022-07-11 1:13 pm Purchase | 13G | NEVRO CORP NVRO | VANGUARD GROUP INC | 3,560,796 10.1% | 375,618 (+11.79%) | View |
2022-02-11 1:54 pm Purchase | 13G | NEVRO CORP NVRO | Jackson Square Partners LLC | 2,443,095 7% | 2,443,095 (New Position) | View |
2022-02-10 08:27 am Purchase | 13G | NEVRO CORP NVRO | VANGUARD GROUP INC | 3,185,178 9.13% | 84,942 (+2.74%) | View |